Cite
HARVARD Citation
Yamamoto, K. et al. (2022). Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy. Japanese journal of clinical oncology. pp. 29-38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamamoto, K. et al. (2022). Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy. Japanese journal of clinical oncology. pp. 29-38. [Online].